As of 2025-09-18, the Relative Valuation of Cannara Biotech Inc (LOVE.CN) is (0.51) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.12 CAD, the upside of Cannara Biotech Inc based on Relative Valuation is -528.7%.
The range of the Relative Valuation is (0.66) - (0.33) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 36.6x - 42.1x | 39.3x |
| Forward P/E multiples | 16.8x - 18.0x | 17.4x |
| Fair Price | (0.66) - (0.33) | (0.51) |
| Upside | -647.5% - -377.2% | -528.7% |
| Date | P/E |